Recommendation to Use Wearable-Based mHealth in Closed-Loop Management of Acute Cardiovascular Disease Patients During the COVID-19 Pandemic

Because of the rapid and serious nature of acute cardiovascular disease (CVD) especially ST segment elevation myocardial infarction (STEMI), a leading cause of death worldwide, prompt diagnosis and treatment is of crucial importance to reduce both mortality and morbidity. During a pandemic such as c...

Full description

Saved in:
Bibliographic Details
Published in:IEEE journal of biomedical and health informatics 2021-04, Vol.25 (4), p.903-908
Main Authors: Ji, Nan, Xiang, Ting, Bonato, Paolo, Lovell, Nigel H., Ooi, Sze-Yuan, Clifton, David A., Akay, Metin, Ding, Xiao-Rong, Yan, Bryan P., Mok, Vincent, Fotiadis, Dimitrios I., Zhang, Yuan-Ting
Format: Article
Language:English
Subjects:
Acute Disease
Biomedical monitoring
Cardiovascular disease
Cardiovascular diseases
Cardiovascular Diseases - complications
Cardiovascular Diseases - diagnosis
Cardiovascular Diseases - therapy
Coronaviruses
COVID-19
COVID-19 - complications
COVID-19 - epidemiology
COVID-19 - prevention & control
Diseases
Health risks
Heart diseases
Hospitals
Humans
mobile health
Monitoring
Monitoring, Ambulatory - instrumentation
Monitoring, Ambulatory - methods
Morbidity
Myocardial infarction
Pandemics
physiological monitoring
Remote monitoring
Risk Factors
Risk management
SARS-CoV-2
ST Elevation Myocardial Infarction - complications
ST Elevation Myocardial Infarction - diagnosis
ST Elevation Myocardial Infarction - therapy
Telemedicine
Viral diseases
Wearable Electronic Devices
Wearable technology
wearables
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Because of the rapid and serious nature of acute cardiovascular disease (CVD) especially ST segment elevation myocardial infarction (STEMI), a leading cause of death worldwide, prompt diagnosis and treatment is of crucial importance to reduce both mortality and morbidity. During a pandemic such as coronavirus disease-2019 (COVID-19), it is critical to balance cardiovascular emergencies with infectious risk. In this work, we recommend using wearable device based mobile health (mHealth) as an early screening and real-time monitoring tool to address this balance and facilitate remote monitoring to tackle this unprecedented challenge. This recommendation may help to improve the efficiency and effectiveness of acute CVD patient management while reducing infection risk.
ISSN:2168-2194
2168-2208
DOI:10.1109/JBHI.2021.3059883